ASCENDIA PHARMACEUTICAL SOLUTIONS Trademark

Trademark Overview

On Thursday, September 2, 2021, a trademark application was filed for ASCENDIA PHARMACEUTICAL SOLUTIONS with the United States Patent and Trademark Office. The USPTO has given the ASCENDIA PHARMACEUTICAL SOLUTIONS trademark a serial number of 97008685. The federal status of this trademark filing is REGISTERED as of Tuesday, July 15, 2025. This trademark is owned by Ascendia Pharmaceuticals, Inc.. The ASCENDIA PHARMACEUTICAL SOLUTIONS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development of pharmaceuticals designed via physical means to be released into the body over a period of time
ascendia pharmaceutical solutions

General Information

Serial Number97008685
Word MarkASCENDIA PHARMACEUTICAL SOLUTIONS
Filing DateThursday, September 2, 2021
Status700 - REGISTERED
Status DateTuesday, July 15, 2025
Registration Number7868322
Registration DateTuesday, July 15, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements

NOT AVAILABLE"PHARMACEUTICAL SOLUTIONS"
Goods and Servicesresearch and development of pharmaceuticals designed via physical means to be released into the body over a period of time

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 15, 2021
Primary Code042
First Use Anywhere DateFriday, December 6, 2024
First Use In Commerce DateFriday, December 6, 2024

Trademark Owner History

Party NameAscendia Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902
Party NameAscendia Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902
Party NameAscendia Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902

Trademark Events

Event DateEvent Description
Wednesday, June 8, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, June 8, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 6, 2021NEW APPLICATION ENTERED
Friday, October 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 7, 2022ASSIGNED TO EXAMINER
Wednesday, June 8, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 8, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 6, 2023SOU EXTENSION 1 FILED
Monday, March 6, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 23, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2023SOU EXTENSION 2 FILED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 12, 2024SOU EXTENSION 3 FILED
Wednesday, August 14, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 12, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 12, 2024SOU EXTENSION 3 GRANTED
Tuesday, February 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU EXTENSION 4 FILED
Wednesday, August 14, 2024SOU EXTENSION 4 GRANTED
Wednesday, March 5, 2025USE AMENDMENT FILED
Thursday, March 6, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, August 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 29, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, May 30, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 25, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 15, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, July 15, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, July 16, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

solutions pharmaceutical ascendia body over period time released means development pharmaceuticals designed physical